It was found that BM-MSCs can significantly improve renal histology and systemic homeostasis by upregulating the serum levels of anti-inflammatory cytokines, such as epidermal growth factor (EGF) and IL-10, thus prevent renal insufficiency and glomerular sclerosis. The gene discussed is EGF; the disease is glomerulosclerosis.